Apollo Medical Holdings is a physician-centric integrated population health management company providing coordinated, outcomes-based medical care and serving patients in California, the majority of whom are covered by private or public insurance provided through Medicare, Medicaid and health maintenance organizations. The company provides care coordination services to each main constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. The company's physician network consists of primary care physicians, specialist physicians and hospitalists.

Arcturus Therapeutics is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome. The most common available treatments for ADHD are stimulants that increase the brain chemicals dopamine and norepinephrine. Stimulants have significant side effects, and are classified as controlled substances which have significant potential for misuse, abuse and addiction. MDX is not a stimulant, and works with a different mechanism of action. MDX is a proprietary, combined rapid onset release formulation of the chemical Pyridoxine Pyroglutamate.

Associated Capital Group provides alternative investment management services and institutional research services, as well as management of its proprietary investment portfolio. In its alternative asset management operations, subsidiaries of the company serve as general partner or investment manager to investment funds including limited partnerships, offshore companies and separate accounts. The company primarily manages assets in equity event-driven value strategies, across a range of risk and event arbitrage portfolios. Also, the company provides institutional research services through its subsidiary, G.research, LLC, which is a broker-dealer and also acts as an underwriter primarily for the company's affiliates.

Bloom Energy designs, manufactures, and sells solid-oxide fuel cell systems, or Energy Servers, for on-site power generation. The company's Energy Servers utilize a fuel cell technology. The company's solution, the Bloom Energy Server, is a stationary power generation platform. The Bloom Energy Server converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion.

CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of healthcare solutions for transplant patients and caregivers. The company provides testing services, products, and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. The company's testing services consist of AlloSure? Kidney, which is a donor-derived cell-free DNA solution for kidney transplant patients, and AlloMap? Heart, which is a gene expression solution for heart transplant patients.

Centennial Resource Development is an independent oil and natural gas company focused on the development of unconventional oil and associated natural gas reserves in the Permian Basin.

Cognizant Technology Solutions is a services company, transforming customers' business, operating and technology models for the digital era. The company's services include digital services and solutions, consulting, application development, systems integration, application testing, application maintenance, infrastructure services and business process services. Additionally, the company develops, licenses, implements and supports proprietary and third-party software products and platforms. The company has organized its services and solutions into four practice areas: Digital Business, Digital Operations, Digital Systems and Technology and Consulting.

Enterprise Products Partners is a provider of midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals and refined products. The company's midstream energy operations include: natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage, and export and import terminals; crude oil gathering, transportation, storage, and export and import terminals; petrochemical and refined products transportation, storage, export and import terminals, and related services; and a marine transportation business that operates primarily on the U.S. inland and Intracoastal Waterway systems.

Evolent Health is a holding company. Through its subsidiaries, the company is a managed care services firm that supports health systems and physician organizations in their migration toward care and population health management. The company's Services segment provides its customers, who it refers to as partners, with a population health management platform, integrated data and analytics capabilities, claims processing services, including pharmacy benefit management, specialty care management services and health plan administration services. The company's subsidiary, True Health New Mexico, Inc. is a physician-led health plan in New Mexico available via the commercial market for employer-sponsored health coverage.

Globalstar provides mobile satellite services including voice and data communications services via satellite. The company provides the following communications services via satellite: two-way voice communication and data transmissions using mobile or fixed devices including its GSP-1700 phone; one-way or two-way communication and data transmissions using mobile devices, including its SPOT family of products such as SPOT X?, SPOT Gen3 and Trace; and one-way data transmissions using a mobile or fixed device that transmits its location and other information to a central monitoring station, including its commercial Simplex products, such as its battery and solar-powered SmartOne, STX-3 and STINGR.

Great Lakes Dredge & Dock is a provider of dredging services. The company provides dredging services in the East, West, and Gulf Coasts of the U.S. and worldwide. The company operates in one operating segment, which is also the company's sole reportable segment and reporting unit. Dredging generally involves the enhancement or preservation of navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand or rock. Domestically, the company's work generally is performed in coastal waterways and deep water ports. The U.S. dredging market consists of four primary types of work: capital, coastal protection, maintenance and rivers and lakes.

Health Insurance Innovations is a holding company. Through its subsidiaries, the company is engaged as a cloud-based technology platform and distributor of individual and family health insurance plans (IFP) which include short-term medical insurance plans, and health benefit insurance plans. The company provides numerous supplemental insurance and non-insurance products, including life insurance policies, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and pharmacy benefit cards, that are purchased as supplements to IFPs.

MTS Systems supplies test, simulation and measurement systems and sensors. The company's Test and Simulation segment provides testing solutions including hardware, software and services. Products, service and customers are grouped into three global sectors: ground vehicles, materials, and structures. The company's Sensors segment is engaged in sensing technologies and solutions used by design engineers and predictive maintenance personnel. Sensors products and solutions serve the automotive, aerospace, industrial, defense, and research and development markets. Sensors products and customers are grouped into four global sectors: positional sensors, test sensors, industrial sensors, and systems sensors.

New Mountain Finance is a closed-end, non-diversified management investment company that is engaged in the sourcing and origination of debt securities at various levels of the capital structure, including first and second lien debt, notes, bonds and mezzanine securities. In some cases, the company's investments may also include equity interests. The company makes investments through both primary originations and open-market secondary purchases.

Ocugen is focused on its product, NeoCart?, a cell therapy that utilizes various aspects of the company's restorative cell therapy platform to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company's NeoCart Phase 3 clinical trial is designed, randomized clinical trial in North America evaluating the safety and efficacy of a restorative cell therapy to treat knee cartilage damage. The company has a License and Commercialization Agreement with MEDINET Co., Ltd. with regards to the commercialization of NeoCart in Japan. HISTOGENICS (and design), its logo design and NEOCART are the company's registered trademarks.